Community-based MRSA. A new challenge for dermatology;Community MRSA. Eine neue herausforderung für die dermatologie

Hautarzt

Volumn 56, Issue 8, 2005, Pages 731-738

  Witte, W ^a   Wiese Posselt, M ^a   Jappe, U ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Antibiotic resistance; Community acquired MRSA; Methicillin resistant Staphylococcus aureus; Skin and soft tissue infections; Staphylococcus aureus

Indexed keywords

BETA LACTAM ANTIBIOTIC; LEUKOCIDIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL PRACTICE; COMMUNITY; DERMATOLOGY; ENVIRONMENT; GENOMICS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PNEUMONIA; PROPHYLAXIS; SKIN INFECTION;

CARRIER STATE; COMMUNITY-ACQUIRED INFECTIONS; DERMATOLOGY; GERMANY; HUMANS; METHICILLIN RESISTANCE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PREVALENCE; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 23944460276     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-005-0975-9     Document Type: Article

References (39)

1. Baggett HC, Hennessy TW, Leman R et al. (2003) An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol 24:397-402
2. Bales S, Baumann HG, Schnitzler N (2003) Kommentar und Vorschriftensammlung. In: Bales S, Baumann HG, Schnitzler N (Hrsg) Infektionsschutzgesetz, 2. Aufl. W. Kohlhammer, Stuttgart
3. Barber M (1964) Naturally occurring methicillin-resistant staphylococci. J Gen Microbiol 35:183-190
4. Cole GW, Silverberg NL (1986) The adherence of Staphylococcus aureus to human corneocytes. Arch Dermatol 122:166-169
5. Cho SH, Strickland I, Boguniewicz M et al. (2001) Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. J Allergy Clin Immunol 108:269-274
6. Cho SH, Strickland I, Tomkinson A et al. (2001) Preferential binding of Staphylococcus aureus to skin sites of TH2-mediated inflammation in a murine model. J Invest Dermatol 116:658-663
7. Eckhardt C, Halvosa JS, Ray SM, Blumberg HM (2003) Transmission of methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit from a patient with community-acquired disease. Infect Control Hosp Epidemiol 24:460-461
8. Enright MC, Robinson DA, Randle G et al. (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 99:7687-7692
9. Fridkin SK, Hageman JC, Morrison M et al. (2005) Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352:1436-1444
10. Gillet Y, Issartel B, Vanhems P et al. (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentin leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 359:753-759
11. Hiramatsu K, Cui L, Kuroda M, Ito T (2001) The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 9:486-493
12. Ito T, Ma XX, Takeuchi F et al. (2004) Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, rrcC. Antimicrob. Agents Chemother 48:2637-2651
13. Jappe U, Petzoldt D, Wendt C (2004) Methicillin-resistant Staphylococcus aureus-colonization in inflammatory versus non-inflammatory skin diseases: Who should be screened? Acta Derm Venereol 84:181-186
14. Jappe U, Heuck D, Wendt C et al. (2005) Community-acquired MRSA bei Patienten der dermatologischen Ambulanz: Komplikation durch Panton-Valentine- Leukozidin-Gene und Fusidinsäure-Resistenz. JDDG 3:S136
15. Kazakova SV, Hageman JC, Matava M et al. (2005) A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med. 352:468-475
16. LaMar JE, Carr RB, Zinderman C, McDonald K (2003) Sentinel cases of community-acquired methicillin-resistant Staphylococcus aureus onboard a naval ship. Mil Med 168:135-138
17. Lina G, Piemont Y, Godail-Gamot F et al. (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29:1128-1132
18. Linde HJ, Wagenlehner F, Kleingütl E et al. (2004) Community-acquired MRSA (cMRSA) emerging in Germany: two major hospital(HOSP)/nursing home(NN)-related outbreaks paralleled by sporadic cases from the community setting (CS). Int J Med Microbiol 294 [Suppl 1]:123
19. Miller LG, Perdreau-Remington F, Rieg G et al. (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352:1445-1453
20. Miller SJ, Aly R, Shinefeld HR et al. (1988) In vitro and in vivo anti-staphylococcal activity of human stratum corneum lipids. Arch Dermatol 124:209-215
21. Morishita Y, Tada J, Sato A et al. (1999) Possible influences of Staphylococcus aureus on atopic dermatitis - the colonizing features and the effects of staphylococcal enterotoxins. Clin Exp Allergy 29:1110-1117
22. Müller-Premru M, Strommenger B, Witte W et al. (2005) Report on strains of community-acquired methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin, causing an outbreak of severe soft-tissue infection in a sport-team. Eur J Clin Microbiol Infect Dis 24 (accepted)
23. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003; 52:88
24. RKI (2005) Fachtagung der AG Nosokomiale Infektionen am RKI zur Intensivierung von Präventionsstrategien bei MRSA. Epidemiol Bull 5:31-38
25. RKI: Staphylokokken-Erkrankungen, insbesondere Infektionen durch MRSA. http//www.rki.de (Link: RKI-Ratgeber, Merkblätter)
26. Robert Koch-Institut (1999) Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen. Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am RKI. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 42:954-958
27. Robert Koch-Institut (2003) Liste der vom Robert Koch-Institut geprüften und anerkannten Desinfektionsmittel und -Verfahren. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 46:72-95
28. Robert Koch-Institut (2005) Ausbruch von Furunkulose durch lukS-lukF-positive Staphylococcus aureus in einem Dorf in Brandenburg, 2002-2004. Epidemiol Bull 10:79-83
29. Robinson DA, Kearns AM, Holmes A et al. (2005) Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet 365:1256-1258
30. Roll A, Cozzio A, Fischer B, Schmid-Grendelmeier P (2004) Microbial colonization and atopic dermatitis. Curr Opin Allergy Clin Immunol 4:373-378
31. Saiman L, O'Keefe M, Graham PL 3rd et al.(2003) Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 37:1313-1319
32. Tiemersma EW, Bronzwaer SL, Lyytikainen O et al. (2004) European Antimicrobial Resistance Surveillance System Participants. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 10:1627-1634
33. Vandenesch F, Naimi I, Enright MC et al. (2003) Community-acquired methicillin-resistant Staphylococcus aureus carrying panton-valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9:978-984
34. Wannet W, Heck M, Pluister G et al. (2004) Panton-Valentine leukociding positive MRSA in 2003: the Dutch situation. Eurosurveillance 9:11
35. Witte W, Rauterberg A, Zimmermann O et al. (2003) Are there community MRSA in central Europe? Int J Med Microbiol 293 [Suppl] 36:432
36. Witte W, Cuny C, Strommenger B et al. (2004) Emergence of a new community acquired MRSA strain in Germany. Eurosurveillance 9:16-18. http://www. eurosurveillance.org/cm/v09n01/0901-222.aso
37. Witte W, Strommenger B, Klare I, Werner G (2004) Antibiotic-resistant nosocomial pathogens. Part I: diagnostic and typing methods. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47:352-362
38. Young DM, Harris HW, Charlebois ED et al. (2004) An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg 139:947-951
39. Zinderman CE, Conner B, Malakooti MA et al. (2004) Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 10:941-944